Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | LPO | P22079 | 1/20 | 0.31 |
| ▸ | PTP4A3 | O75365 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4256486 | 0.84 | LPO (0.39) | HTTMEN1KMT2AALDH1A1HPGD | |
| SCHEMBL4259643 | 0.84 | LPO (0.39) | HTTMEN1KMT2AALDH1A1HPGD | |
| SCHEMBL14769326 | 0.80 | ALDH1A1 (0.39) | HTTMEN1KMT2AALDH1A1HPGD | |
| SCHEMBL14769322 | 0.75 | LPO (0.32) | LPOPTP4A3 | |
| SCHEMBL14769323 | 0.75 | LPO (0.32) | HTTMEN1KMT2ALPOPTP4A3 | |
| SCHEMBL1254916 | 0.70 | LPO (0.43) | HTTMEN1KMT2AALDH1A1HPGD | |
| SCHEMBL19999314 | 0.69 | — | — | |
| SCHEMBL13351500 | 0.68 | PTP4A3 (0.36) | HTTMEN1KMT2ALPOPTP4A3 | |
| SCHEMBL11694307 | 0.68 | NR4A1 (0.45) | MEN1KMT2AALDH1A1HPGD | |
| SCHEMBL11694311 | 0.68 | NR4A1 (0.45) | MEN1KMT2AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9545623-B2 | Nickel-based catalytic composition and method of oligomerization of olefins using said composition | IFP Energies Nouvelles (FR) | 2017-01-17 | — | — | US | disclosed |
| US-20130066128-A1 | NOVEL NICKEL-BASED CATALYTIC COMPOSITION AND METHOD OF OLIGOMERIZATION OF OLEFINS USING SAID COMPOSITION | IFP Energies Nouvelles (FR) | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130066128-A1 | NOVEL NICKEL-BASED CATALYTIC COMPOSITION AND METHOD OF OLIGOMERIZATION OF OLEFINS USING SAID COMPOSITION | POR, NIT2, NOD2 | HTT 2708/4885MEN1 875/4885KMT2A 2736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.